Indirubin-3-monoxime exhibits anti-inflammatory properties by down-regulating NF-κB and JNK signaling pathways in lipopolysaccharide-treated RAW264.7 cells

NF-κB, Inflammation, and Metabolic Disease

(2011) Rebecca G. Baker et al.   Cell Metabolism

Indirubin-3'-monoxime, a derivative of a chinese antileukemia medicine, inhibits angiogenesis

(2011) Jin-Kyung Kim et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Molecular pathways and targets in cancer-related inflammation

(2010) Alberto Mantovani et al.   ANNALS OF MEDICINE

MAPK signaling pathways in the regulation of hematopoiesis

(2009) Christian R. Geest et al.   JOURNAL OF LEUKOCYTE BIOLOGY

7-Bromoindirubin-3′-oxime uncovers a serine protease-mediated paradigm of necrotic cell death

(2008) Judit Ribas et al.   BIOCHEMICAL PHARMACOLOGY

Dietary management of the metabolic syndrome beyond macronutrients

(2008) Deanna M Minich et al.   NUTRITION REVIEWS